Second Trump appointee out at FDA amid credibility concerns
WASHINGTON (AP) — A second Trump administration appointee has been ousted at the Food and Drug Administration in the wake of the agency's botched announcement about an experimental therapy for COVID-19, which medical experts said damaged the health regulator's credibility with the public.
Become a Subscriber!
You have read all of your free articles this month. Select a plan below to start your subscription today.
Already a subscriber? Login
